SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the stock surpasses $5, triggering increased community discussion around potential catalysts and future price movement. Investors are also reacting to recent analyst upgrades, while some express frustration with the stock's historical performance and perceived manipulation. The community is actively debating the company's QNX technology and its potential in various sectors.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to a newly announced deal with Fluidstack and backing from Google, with the community actively discussing the implications of the partnership and a related offering. Community members are focused on the potential for significant growth and a possible gamma squeeze, while also noting the company's commitment to avoiding dilution. The broader context involves Cipher's expansion into AI data centers and high-performance computing.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as speculation mounts around potential investments from major players like Apple and strategic partnerships with TSMC, with community members actively discussing a possible weekend announcement related to Apple. The surge is further fueled by government initiatives to boost domestic chip production, although some traders express concerns about overbought conditions and potential profit-taking. Bullish sentiment remains strong as investors anticipate substantial growth and the return of Intel as a dominant force in the semiconductor industry.

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BioAffinity Technologies Inc

BioAffinity Technologies is trending due to positive clinical results for its CyPath Lung test, which detects early-stage lung cancer; the news is driving community interest given the stock's low float. Community members are discussing the potential for a significant market cap increase given its focus on cancer detection. Some are wary of dilution, while others point to a potential short squeeze.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors weigh the impact of potential government funding changes and a possible government shutdown on the company's operations. Community discussions revolve around technical analysis, potential short squeezes, and the strategic importance of rare earth elements for national security. Some are concerned about rumors of pulled funding while others see the dip as a buying opportunity, emphasizing the company's critical role in the U.S. supply chain and national security.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss its ties to crypto, particularly Tether's significant ownership and potential funding opportunities. Community members are speculating on the implications of Tether's involvement and potential cloud deals, while also noting the high short interest in the stock. Some are also pointing to political connections and potential government contracts as possible catalysts.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

IREN is trending due to bullish sentiment around its AI data center business, despite some community members noting a recent pullback in the energy sector and analyst downgrades. Some traders are discussing the potential for a short squeeze, while others point to the stock's long-term potential in the AI space. Community members are actively debating recent price action and future price targets.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQQF is trending due to community discussions around its Nasdaq uplisting, the potential for increased exposure, and the shift to the new ticker symbol BTQ. Concerns about potential dilution and price manipulation are being weighed against bullish sentiment regarding the company's position in the quantum cybersecurity space and a possible upcoming 

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending as the community anticipates upcoming earnings and discusses the potential impact of the Alani Nu acquisition and Pepsi distribution deal. Bullish sentiment is fueled by strong sales data and analysts' price targets, while some investors express frustration with recent price action and perceived manipulation. The community also discusses the potential for CELH to gain market share from competitors like Monster and Rockstar.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending due to the FDA approval of Palsonify, a once-daily oral drug for acromegaly, with anticipation building for its market availability in early October. Community members are discussing the potential for significant sales and a possible short squeeze, as well as analyst price target upgrades. Despite recent gains, some traders believe the stock is undervalued given its pipeline and potential expansion into Europe.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?

Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.

Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top

HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.

Henry Schein (HSIC) Q2 Earnings Lag Estimates

Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein (HSIC) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Henry Schein to Report Q2 Earnings: What's in Store for the Stock?

HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.

Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.

Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein Inc.

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

HSIC
Henry Schein Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HSIC News

HSIC Henry Schein Inc.